Unknown

Dataset Information

Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse.


ABSTRACT:

Aim

This report examined naturalistic opioid use outcomes and utilization of medications for opioid use disorder (MOUD) 36 weeks post-randomization in the National Drug Abuse Treatment Clinical Trials Network (CTN) Extended-Release Naltrexone (XR-NTX) versus Buprenorphine-Naloxone (BUP-NX) for Opioid Treatment trial (CTN-0051, X:BOT).

Design

X:BOT was a multisite, randomized, 24-week comparative effectiveness trial of BUP-NX (N = 287) and XR-NTX (N = 283). Study medications were discontinued following treatment completion, relapse, or dropout. Participants were encouraged to continue MOUD. This report examined opioid use outcomes in 428 (75%) of the 570 participants who attended the 36-week follow-up visit.

Setting and participants

Adults with opioid use disorder recr

SUBMITTER: Greiner MG 

PROVIDER: S-EPMC8556394 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature